Sign in

CIK 0001650664

  • Non-accelerated filer
  • Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464097528
Phone
+1 617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market sale EVP/Chief Scientific Officer sold 151 shares at $25.28 ($3,817)
  7. 4 Open-market sale Chief Scientific Officer sold 622 shares at $26.95 ($16,763)
  8. 4 Grant or award CEO acquired 15,625 shares (grant or award)
  9. 4 Open-market sale Chief Scientific Officer sold 5,549 shares at $26.54 ($147,288)
  10. 4 Grant or award Chief Financial Officer acquired 20,000 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Grant or award Chief Medical Officer acquired 25,000 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Grant or award CEO acquired 20,000 shares (grant or award)
  15. 4 Open-market sale CEO sold 5,193 shares at $25.83 ($134,135)
  16. 4 Grant or award CEO acquired 8,283 shares (grant or award)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 10 of 18 · 351 filings